Markel promotes medical testing liability product
Markel (UK), the regional arm of Markel International, has launched a liability product aimed at protecting the medical and pharmaceutical industries. The product, Speciality Liability covers the following areas specifically; surgical, pharmaceutical and drug, supplement and cosmetic and scientific and technical equipment manufacturing, distribution and design industries.
These professions are under ever increasing pressure to push the boundaries of medical science with the resulting consequence being that occasional blunders are inevitable, Markel said.
Recent news
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe
You are currently unable to print this content. Please contact info@postonline.co.uk to find out more.
You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@postonline.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@postonline.co.uk
More on Commercial
How Covid-19 litigation has shifted BI policy wording
Joanna Grant, managing partner of Fenchurch Law, explores how business interruption insurance has evolved five years on from the pandemic, and whether the lessons of Covid-19 are being properly applied today.
Diary of an Insurer: QBE’s Hannah Wilkinson
Hannah Wilkinson, motor trade underwriting manager of QBE, gets her team's pipeline, performance and priorities ready for 2026, collaborates with cyber underwriting colleagues, and looks forward to the wonderful mayhem of a family weekend.
Insurance Post’s star-studded Christmas Special for 2025
The award-winning Insurance Post Podcast has signed off the year with a Christmas Special featuring industry heavyweights, newsroom favourites and even a CBeebies-style bedtime story.
MGAs Review of the Year 2025
2025 was a landmark year for MGAs, marked by record growth, major partnerships, technological innovation and expanding global reach, even as soft market conditions and pricing pressures tested resilience across the sector.
Five insurance M&A storylines to follow in 2026
As we bid farewell to 2025, Post content director Jonathan Swift highlights the M&A storylines that might make the transition from rumour to reality next year and beyond.
Regulator urged to act to avert Covid BI lawsuit wave
Law firm Stewarts has written to the Financial Conduct Authority to ask it to issue urgent ‘stop the clock’ guidance on Covid business interruption claims, in order to avoid a wave of lawsuits in the new year.
Insurers Review of the Year 2025
Insurers managed to post profits amid a softening market in 2025, invested in technology and pushed to reaffirm the industry’s vital role in protecting society with the Labour government and regulators.
Potholes put councils on legal front line over road repairs
As pothole-related injury and damage claims increase, Georgia Milton, paralegal at DWF, warns councils and insurers must navigate complex legal duties, evidential hurdles and financial risks in proving when liability begins.